These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 30708268
21. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort. Jääskeläinen T, Heinonen S, Hämäläinen E, Pulkki K, Romppanen J, Laivuori H, FINNPEC. Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331 [Abstract] [Full Text] [Related]
22. Longitudinal changes in maternal hemodynamics in a population at risk for pre-eclampsia. Khalil A, Garcia-Mandujano R, Maiz N, Elkhouli M, Nicolaides KH. Ultrasound Obstet Gynecol; 2014 Aug; 44(2):197-204. PubMed ID: 24652784 [Abstract] [Full Text] [Related]
23. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor. Rohra DK, Zeb A, Qureishi RN, Azam SI, Khan NB, Zuberi HS, Sikandar R. Natl Med J India; 2012 Aug; 25(2):68-73. PubMed ID: 22686711 [Abstract] [Full Text] [Related]
24. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio. Buhimschi CS, Baumbusch MA, Dulay AT, Lee S, Wehrum M, Zhao G, Bahtiyar MO, Pettker CM, Ali UA, Funai EF, Buhimschi IA. BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826 [Abstract] [Full Text] [Related]
25. First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk. Rezk M, Gaber W, Shaheen A, Nofal A, Emara M, Gamal A, Badr H. Hypertens Pregnancy; 2018 Aug; 37(3):111-117. PubMed ID: 29893156 [Abstract] [Full Text] [Related]
26. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia]. Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X. Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913 [Abstract] [Full Text] [Related]
27. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C, Moya W, Rodriguez O, Jijón A, Geipel A. J Matern Fetal Neonatal Med; 2016 Jan; 29(4):537-43. PubMed ID: 25708492 [Abstract] [Full Text] [Related]
28. Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy. Liu SY, Chen J, Li YF. J Diabetes Investig; 2018 Sep; 9(5):1182-1188. PubMed ID: 29489069 [Abstract] [Full Text] [Related]
29. A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation. Hirashima C, Ohkuchi A, Takahashi K, Suzuki H, Matsubara S, Suzuki M. Hypertens Res; 2014 Jun; 37(6):519-25. PubMed ID: 24599015 [Abstract] [Full Text] [Related]
30. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia. Duan H, Zhao G, Xu B, Hu S, Li J. Clin Lab; 2017 May 01; 63(5):921-925. PubMed ID: 28627818 [Abstract] [Full Text] [Related]
31. Comparison of Placental Growth Factor Levels in Maternal Serum at Early Pregnancy between Normotensive Pregnant Women and Patients with Hypertensive Disorders in Pregnancy. Sultana MT, Begum F, Akhter N, Parveen T, Kakan FB, Sattar MS. Mymensingh Med J; 2020 Jul 01; 29(3):609-615. PubMed ID: 32844801 [Abstract] [Full Text] [Related]
32. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R. Acta Obstet Gynecol Scand; 2008 Jul 01; 87(8):837-42. PubMed ID: 18607829 [Abstract] [Full Text] [Related]
33. Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. Kumar N, Singh AK. Curr Hypertens Rev; 2019 Jul 01; 15(2):154-160. PubMed ID: 30417791 [Abstract] [Full Text] [Related]
35. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation. Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Ultrasound Obstet Gynecol; 2017 Nov 01; 50(5):589-595. PubMed ID: 28556556 [Abstract] [Full Text] [Related]
36. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. Andersen LB, Dechend R, Jørgensen JS, Luef BM, Nielsen J, Barington T, Christesen HT. Hypertens Pregnancy; 2016 Aug 01; 35(3):405-19. PubMed ID: 27159383 [Abstract] [Full Text] [Related]
37. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease. Fernández-Laso V, Méndez-Barbero N, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM. Atherosclerosis; 2017 May 01; 260():130-137. PubMed ID: 28390291 [Abstract] [Full Text] [Related]
38. Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia. Wright D, Krajewska K, Bogdanova A, Wright A, Nicolaides KH. Ultrasound Obstet Gynecol; 2016 Jun 01; 47(6):755-61. PubMed ID: 26726123 [Abstract] [Full Text] [Related]
39. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study. Kuessel L, Zeisler H, Ristl R, Binder J, Pateisky P, Schmid M, Marschalek J, Perkmann T, Haslacher H, Husslein H. BMC Pregnancy Childbirth; 2016 Nov 03; 16(1):339. PubMed ID: 27809797 [Abstract] [Full Text] [Related]
40. Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers. Costa RA, Hoshida MS, Alves EA, Zugaib M, Francisco RP. Hypertens Pregnancy; 2016 May 03; 35(2):139-49. PubMed ID: 26930132 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]